CAS 2383086-06-2

Formula: C49H59N7O7S

InChI: InChI=1S/C49H59N7O7S/c1-32(2)39-7-4-5-8-40(39)43-9-6-22-55(43)36-28-49(29-36)19-23-54(24-20-49)35-10-12-41(45(26-35)63-37-25-34-16-21-50-46(34)52-31-37)47(57)53-64(61,62)38-11-13-42(44(27-38)56(59)60)51-30-33-14-17-48(3,58)18-15-33/h4-5,7-8,10-13,16,21,25-27,31-33,36,43,51,58H,6,9,14-15,17-20,22-24,28-30H2,1-3H3,(H,50,52)(H,53,57)/t33?,43-,48?/m0/s1

InChI key: ZQTKOYMWCCSKON-HCWAPQBJSA-N

SMILES: CC(C)C1=CC=CC=C1[C@@H]2CCCN2C3CC4(C3)CCN(CC4)C5=CC(=C(C=C5)C(=O)NS(=O)(=O)C6=CC(=C(C=C6)NCC7CCC(CC7)(C)O)[N+](=O)[O-])OC8=CN=C9C(=C8)C=CN9

Sonrotoclax

CAS: 2383086-06-2

Purity: 98%

Ref: IN-DA02DHO4

Sonrotoclax

CAS: 2383086-06-2

Sonrotoclax

Formula: C₄₉H₅₉N₇O₇S

Purity: ≥95%

Molecular weight: 890.1

Ref: 54-BUP22914

Sonrotoclax

CAS: 2383086-06-2

Sonrotoclax is a potent, orally active inhibitor of Bcl2, demonstrating effective cell-killing activity against a range of lymphoma and leukemia cell lines [1].

Formula: C₄₉H₅₉N₇O₇S

Purity: 97.33% - 99.47%

Color and Shape: Yellow Solid

Molecular weight: 890.10

Ref: TM-T74637